<#comment comment=”[if gte mso 9]> Normal 0 21 <#comment comment=” /* Font Definitions */ @font-face {font-family:Helvetica; panose-1:2 11 6 4 2 2 2 2 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:536902279 -2147483648 8 0 511 0;} @font-face {font-family:Wingdings; panose-1:5 0 0 0 0 0 0 0 0 0; mso-font-charset:2; mso-generic-font-family:auto; mso-font-pitch:variable; mso-font-signature:0 268435456 0 0 -2147483648 0;} @font-face {font-family:”Arial Unicode MS”; panose-1:2 11 6 4 2 2 2 2 2 4; mso-font-charset:128; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-1 -369098753 63 0 4129279 0;} @font-face {font-family:Verdana; panose-1:2 11 6 4 3 5 4 4 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:536871559 0 0 0 415 0;} @font-face {font-family:TimesNewRomanPS-BoldMT; panose-1:0 0 0 0 0 0 0 0 0 0; mso-font-charset:0; mso-generic-font-family:roman; mso-font-format:other; mso-font-pitch:auto; mso-font-signature:3 0 0 0 1 0;} @font-face {font-family:”@Arial Unicode MS”; panose-1:2 11 6 4 2 2 2 2 2 4; mso-font-charset:128; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-1 -369098753 63 0 4129279 0;} /* Style Definitions */ p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-parent:””; margin:0cm; margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:12.0pt; font-family:”Times New Roman”; mso-fareast-font-family:”Times New Roman”;} h1 {margin-right:0cm; mso-margin-top-alt:auto; mso-margin-bottom-alt:auto; margin-left:0cm; mso-pagination:widow-orphan; mso-outline-level:1; font-size:24.0pt; font-family:”Arial Unicode MS”; mso-font-kerning:18.0pt; font-weight:bold;} h2 {margin-right:0cm; mso-margin-top-alt:auto; mso-margin-bottom-alt:auto; margin-left:0cm; mso-pagination:widow-orphan; mso-outline-level:2; font-size:18.0pt; font-family:”Arial Unicode MS”; font-weight:bold;} h3 {margin-right:0cm; mso-margin-top-alt:auto; mso-margin-bottom-alt:auto; margin-left:0cm; mso-pagination:widow-orphan; mso-outline-level:3; font-size:13.5pt; font-family:”Arial Unicode MS”; font-weight:bold;} h4 {mso-style-next:Normal; margin:0cm; margin-bottom:.0001pt; mso-pagination:widow-orphan; page-break-after:avoid; mso-outline-level:4; mso-layout-grid-align:none; text-autospace:none; font-size:11.0pt; mso-bidi-font-size:8.5pt; font-family:TimesNewRomanPS-BoldMT; mso-fareast-font-family:”Times New Roman”; mso-bidi-font-family:”Times New Roman”; font-weight:bold;} h5 {mso-style-next:Normal; margin:0cm; margin-bottom:.0001pt; mso-pagination:widow-orphan; page-break-after:avoid; mso-outline-level:5; mso-layout-grid-align:none; text-autospace:none; font-size:12.0pt; mso-bidi-font-size:8.5pt; font-family:TimesNewRomanPS-BoldMT; mso-fareast-font-family:”Times New Roman”; mso-bidi-font-family:”Times New Roman”; font-weight:bold;} h6 {margin-right:0cm; mso-margin-top-alt:auto; mso-margin-bottom-alt:auto; margin-left:0cm; mso-pagination:widow-orphan; mso-outline-level:6; font-size:7.5pt; font-family:”Arial Unicode MS”; font-weight:bold;} p.MsoBodyText, li.MsoBodyText, div.MsoBodyText {margin:0cm; margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:12.0pt; font-family:Helvetica; mso-fareast-font-family:”Times New Roman”; color:white; mso-ansi-language:EN-GB;} p.MsoBodyTextIndent, li.MsoBodyTextIndent, div.MsoBodyTextIndent {margin-right:0cm; mso-margin-top-alt:auto; mso-margin-bottom-alt:auto; margin-left:18.0pt; mso-pagination:widow-orphan; font-size:12.0pt; font-family:”Times New Roman”; mso-fareast-font-family:”Times New Roman”; color:blue; mso-ansi-language:FR; font-weight:bold;} p.MsoBodyTextIndent2, li.MsoBodyTextIndent2, div.MsoBodyTextIndent2 {margin-right:0cm; mso-margin-top-alt:auto; mso-margin-bottom-alt:auto; margin-left:18.0pt; mso-pagination:widow-orphan; font-size:12.0pt; font-family:”Times New Roman”; mso-fareast-font-family:”Times New Roman”;} a:link, span.MsoHyperlink {color:blue; text-decoration:underline; text-underline:single;} a:visited, span.MsoHyperlinkFollowed {color:purple; text-decoration:underline; text-underline:single;} p {margin-right:0cm; mso-margin-top-alt:auto; mso-margin-bottom-alt:auto; margin-left:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:”Arial Unicode MS”;} span.links5130217 {mso-style-name:links5130217;} span.inicommentsubject {mso-style-name:ini_commentsubject;} span.links5130244 {mso-style-name:links5130244;} span.links5130230 {mso-style-name:links5130230;} p.date, li.date, div.date {mso-style-name:date; margin-right:0cm; mso-margin-top-alt:auto; mso-margin-bottom-alt:auto; margin-left:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:”Arial Unicode MS”;} p.first, li.first, div.first {mso-style-name:first; margin-right:0cm; mso-margin-top-alt:auto; mso-margin-bottom-alt:auto; margin-left:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:”Arial Unicode MS”;} span.artigoautor {mso-style-name:artigoautor;} span.uline {mso-style-name:uline;} span.ticker {mso-style-name:ticker;} span.vcardbyline {mso-style-name:”vcard byline”;} span.dateline {mso-style-name:dateline;} span.posted {mso-style-name:posted;} span.links5135923 {mso-style-name:links5135923;} span.leadartigo {mso-style-name:leadartigo;} p.bodycontent, li.bodycontent, div.bodycontent {mso-style-name:bodycontent; margin-right:0cm; mso-margin-top-alt:auto; mso-margin-bottom-alt:auto; margin-left:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:Verdana; mso-fareast-font-family:”Arial Unicode MS”; mso-bidi-font-family:”Arial Unicode MS”; color:black;} p.bodyquote, li.bodyquote, div.bodyquote {mso-style-name:bodyquote; margin-right:0cm; mso-margin-top-alt:auto; margin-bottom:0cm; margin-left:0cm; margin-bottom:.0001pt; text-align:center; mso-pagination:widow-orphan; font-size:12.0pt; font-family:Arial; mso-fareast-font-family:”Arial Unicode MS”; color:#663399; font-weight:bold;} p.bodyquoteauthor, li.bodyquoteauthor, div.bodyquoteauthor {mso-style-name:bodyquoteauthor; margin-right:0cm; margin-top:0cm; mso-margin-bottom-alt:auto; margin-left:0cm; text-align:center; mso-pagination:widow-orphan; font-size:12.0pt; font-family:Verdana; mso-fareast-font-family:”Arial Unicode MS”; mso-bidi-font-family:”Arial Unicode MS”; color:#663399;} p.communautes-lst-date, li.communautes-lst-date, div.communautes-lst-date {mso-style-name:communautes-lst-date; margin-right:0cm; mso-margin-top-alt:auto; mso-margin-bottom-alt:auto; margin-left:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:”Arial Unicode MS”;} p.communautes-lst-texte, li.communautes-lst-texte, div.communautes-lst-texte {mso-style-name:communautes-lst-texte; margin-right:0cm; mso-margin-top-alt:auto; mso-margin-bottom-alt:auto; margin-left:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:”Arial Unicode MS”;} p.stand-first-alone, li.stand-first-alone, div.stand-first-alone {mso-style-name:stand-first-alone; margin-right:0cm; mso-margin-top-alt:auto; mso-margin-bottom-alt:auto; margin-left:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:”Arial Unicode MS”;} span.sign {mso-style-name:sign;} span.info {mso-style-name:info;} span.tit-reac {mso-style-name:tit-reac;} @page Section1 {size:612.0pt 792.0pt; margin:70.85pt 3.0cm 70.85pt 3.0cm; mso-header-margin:36.0pt; mso-footer-margin:36.0pt; mso-paper-source:0;} div.Section1 {page:Section1;} /* List Definitions */ @list l0 {mso-list-id:281688615; mso-list-type:hybrid; mso-list-template-ids:1219412666 -563171866 -847773246 -573960248 -766838124 -1795896128 -1913755654 1406048268 -1818953042 2046094598;} @list l0:level1 {mso-level-number-format:bullet; mso-level-text:; mso-level-tab-stop:36.0pt; mso-level-number-position:left; text-indent:-18.0pt; mso-ansi-font-size:10.0pt; font-family:Symbol;} @list l1 {mso-list-id:433213859; mso-list-type:hybrid; mso-list-template-ids:477271456 -1900799148 -622679490 -1887161040 -1037250868 -557295868 -793885098 -1445685858 1511809754 -1552674936;} @list l1:level1 {mso-level-number-format:bullet; mso-level-text:; mso-level-tab-stop:36.0pt; mso-level-number-position:left; text-indent:-18.0pt; mso-ansi-font-size:10.0pt; font-family:Symbol;} ol {margin-bottom:0cm;} ul {margin-bottom:0cm;} “>
A Autoridade Nacional do Medicamento e Produtos de Saúde (Infarmed) garantiu ontem (16.11.09) que “os dados analisados continuam a permitir a conclusão de que não há evidência que sugira diferenças no perfil de segurança das vacinas com ou sem adjuvante.”
Não obstante, existem outros dados (ver aqui: http://globalresearch.ca/index.php?context=va&aid=14869) que demonstram que as vacinas podem ser perigosas devido aos adjuvantes.
Adjuvantes são substâncias adicionadas às vacinas para reforçar a sua capacidade imunológica. Existe extensa literatura disponível sobre a toxicidade dos adjuvantes.
A maior parte das vacinas contêm níveis perigosos de mercúrio na forma de timerosal, um mortífero preservativo 50 vezes mais tóxico que o próprio mercúrio [ver nota 9, abaixo].
Em doses elevadas, este adjuvante pode causar distúrbios persistentes no sistema imunológico, perturbações sensoriais, neurológicas, motoras e disfunções comportamentais.
Igualmente associado ao envenenamento pelo mercúrio estão os sintomas de autismo, distúrbios dos níveis de concentração, esclerose múltipla e perturbações da fala.
É totalmente desanconselhável injectar timerosal em lactantes, crianças e grávidas, pois a maioria das doses das vacinas anti-gripais contêm 25 microgramas desse adjuvante.
O panorâma da situação corrente das vacinas da gripe suína (H1N1) mostram que foram contratados pelos Estados cinco grandes laboratórios para produzir as vacinas a distribuir em todo o mundo num negócio de valor superior a €280 mil milhões, a saber:
Baxter International, GlaxoSmithKline, Novartis and Sanofi-Aventis and AstroZeneca [ver nota16, abaixo], tudo com a bênção da Organização Mundial de Saúde.
Fontes: <#comment comment=”[endif]”>
As notas, abaixo, obedecem à ordem enumerada no texto original que está aqui: http://globalresearch.ca/index.php?context=va&aid=14869
9. “Quais os perigos da vacinação compulsiva da gripe suína?”, por Dr. Mercola, Junho de 2009: http://blogs.mercola.com/sites/vitalvotes/archive/2009/07/15/What-are-the-Dangers-of-MandatoryMandatory-Swine-Flu-Vaccination.aspx
16. “Actualização: os laboratórios Baxter não podem aceitar mais encomendas de vacinas para o H1N1”, por Bill Berkerto, em 16 de Julho de 2009, na Reuters: http://www.reuters.com/article/marketsnews/idINN1644290820090716?rpc=33
